• According to Transparency Market Research’s latest report on the global pain management therapeutics market for the historical period 2017–2018 and forecast period 2019–2027, high incidence of chronic pain disorders, easy and effective medications, and higher demand of pain management products are projected to drive the global pain management therapeutics market during the forecast period
  • According to the report, the global pain management therapeutics market was valued at US$ 66.6 Bn in 2018 and is anticipated to expand at a CAGR of 3.7% from 2019 to 2027
fa global pain management therapeutics market

To know the scope of our report Get a Sample on Pain Management Therapeutics Market

Rise in Incidence of Chronic Pain Disorders to Promote Usage of Pain Management Therapeutics: Key Drivers

  • The number of patients suffering from chronic pain is on a constant rise globally. For instance, according to the World Health Organization (WHO), the U.S. had 50 million people suffering from chronic pain in 2018. Additionally, according to a European Pain Federation, around 80 Mn adults in Europe suffers from chronic pain.
  • The global increasing incidence rates of cancer further contribute to the rise in demand for pain management therapeutics. This includes pain occurring from cancer therapy as well as from incursion of cancer cells on to bones and other healthy body parts. WHO projections suggest that the global cancer prevalence will increase by around 75% from 2008 to 2030.
  • Hence, increase in incidence of chronic pain conditions continue to encourage the use of pain management drugs, thereby driving the market.

Get a glimpse of the in-depth analysis through our Report Brochure

Easy & Effective Medications and Higher Demand of c Growth

  • Doctors usually prescribe medicines in the initial stages of pain, followed by other treatment options. Prescription drugs are easy and economical to use at individual level without any ambiguity.
  • Increased awareness about availability of medications for pain management propels consumption and acceptance of pain management drugs over other treatment options. Hence, high availability, easy access, high awareness, cost effectiveness, and quick relief have made pain management therapeutics more preferable to other treatment options.
  • According to National Prescription Audit (May 2019), pain treatment was the fourth largest therapy in the U.S., with about 447 million prescriptions after lipid regulators.
  • However, prescription volume for pain therapy decreased by 4.5% in 2018 as compared to 2017, due to continued implementation of control on volume of dispensing prescriptions for narcotic or opioid pain medicines, thereby reducing the misuse of drugs for non-medical use

Side Effects and Risk of drug abuse with opioids to Hamper Market

  • The common side effects experienced from long-term usage of pain therapeutics include constipation, drowsiness, and respiratory depression. Commonly used NSAIDs for pain management have high risk of gastrointestinal ulceration or bleeding. COX-2 inhibitors were developed to eliminate this risk; however, these led to other issues such as risk of heart attack and stroke due to prolonged use.
  • Prescription drug abuse poses a serious threat to the growth of the pain management therapeutics market due to its harmful long term effects. For instance as per National Institute Drug Abuse USA, more than 2 million people in the United States suffer from substance use disorders related to prescription opioid pain relievers.

Expanding operations in future? To get the perfect launch ask for a custom report 

Global Pain Management Therapeutics Market: Competitive Landscape

  • This report profiles major players in the global pain management therapeutics market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global pain management therapeutics market is highly fragmented, with the presence of a number of international as well as regional players
  • Leading players operating in the global pain management therapeutics market are
    • Pfizer Inc.
    • Depomed, Inc.
    • Endo International plc.
    • Purdue Pharma L.P.
    • Mallinckrodt Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Novartis AG
    • AstraZeneca plc.
    • Johnson & Johnson Services, Inc.
    • Merck & Co., Inc.
    • Abbott Laboratories
    • GlaxoSmithKline plc.

Global Pain Management Therapeutics Market: Key Developments

Key players in the global pain management therapeutics market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global pain management therapeutics market. A few expansion strategies adopted by players operating in the global pain management therapeutics market are:

  • In March 2020, Pfizer Inc. and Eli Lilly and Company received USFDA approval for Tanezumab 2.5 mg administered subcutaneously (SC) in the treatment of chronic pain due to moderate-to-severe osteoarthritis (OA).
  • In November 2019, Novartis AG received USFDA approval Adakveo for pain management in adult and pediatric patients aged 16 years and older with sickle cell disease.

The report on the global pain management therapeutics market discussed individual strategies, followed by company profiles of manufacturers of pain management therapeutics. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global pain management therapeutics market.

Global Pain Management Therapeutics Market - Segmentation

Therapeutics

Anticonvulsants

Antidepressants

Anesthetics

NSAIDS

Opioids

  • Oxycodones
  • Hydrocodones
  • Tramadol
  • Others

Antimigraine Agents

Other Non-narcotic Analgesic

Anticonvulsants

Indication

Neuropathic Pain

Fibromyalgia

Arthritic Pain

Chronic Back Pain

Migraine

Post-Operative Pain

Cancer Pain

Region

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Frequently Asked Questions

The global pain management therapeutics market was worth US$ 66,558.6 Mn and is projected to reach a value of US$ 92,123.4 Mn by the end of 2027

Pain management therapeutics market is anticipated to grow at a CAGR of 3.7% during the forecast period

North America accounted for a major share of the global pain management therapeutics market

Pain management therapeutics market is driven by high incidence of chronic pain disorders, easy and effective medications, and higher demand of pain management products are projected to drive the global market during the forecast period

Key players in the global pain management therapeutics market include Pfizer Inc., Depomed, Inc., Endo International plc. , Purdue Pharma L.P., Mallinckrodt Pharmaceuticals, Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Abbott Laboratories, GlaxoSmithKline plc

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pain Management Therapeutics Market

4. Market Overview

    4.1. Introduction

        4.1.1. Type Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Pain Management Therapeutics Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

    5.1. Chronic Pain Disease Epidemiology, by Region/Major Countries

    5.2. Pipeline Analysis

    5.3. Brand Analysis

    5.4. Most Types of Body Pain Location Globally and Cut By Gender and Parents

    5.5. Most Types of Head Pain Location Globally and Cut By Gender and Parents

6. Global Pain Management Therapeutics Market Analysis and Forecast, by Type

7. Global Pain Management Therapeutics  Market Analysis, By Therapeutics

    7.1. Introduction 

    7.2. Global Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics

    7.3. Global Pain Management Therapeutics Market Forecast, by Therapeutics

        7.3.1. Anticonvulsants

        7.3.2. Antidepressants

        7.3.3. Anesthetics

        7.3.4. NSAIDS

        7.3.5. Opioids

            7.3.5.1. Oxycodones

            7.3.5.2. Hydrocodones

            7.3.5.3. Tramadol

            7.3.5.4. Others

        7.3.6. Antimigraine Agents

        7.3.7. Other Non-narcotic Analgesic

    7.4. Global Pain Management Therapeutics Market Analysis, by Therapeutics

8. Global Pain Management Therapeutics  Market Analysis, By Indication

    8.1. Introduction 

    8.2. Global Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication

    8.3. Global Pain Management Therapeutics Market Forecast, by Indication

        8.3.1. Neuropathic Pain 

        8.3.2. Fibromyalgia 

        8.3.3. Arthritic Pain 

        8.3.4. Chronic Back Pain 

        8.3.5. Migraine 

        8.3.6. Post-Operative Pain 

        8.3.7. Cancer Pain 

    8.4. Global Pain Management Therapeutics Market Analysis, by Indication 

9. Global Pain Management Therapeutics Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Pain Management Therapeutics Market Value Forecast, by Region

        9.2.1. North America 

        9.2.2. Europe 

        9.2.3. Asia Pacific 

        9.2.4. Latin America 

        9.2.5. Middle East & Africa 

    9.3. Global Pain Management Therapeutics Market Attractiveness, by Region

10. North America Pain Management Therapeutics Market Analysis

    10.1. Key Findings

    10.2. North America Pain Management Therapeutics Market Overview

    10.3. North America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country

    10.4. North America Pain Management Therapeutics Market Forecast, by Country

        10.4.1. U.S.

        10.4.2. Canada

    10.5. North America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics

    10.6. North America Pain Management Therapeutics Market Forecast, by Therapeutics

        10.6.1. Anticonvulsants

        10.6.2. Antidepressants

        10.6.3. Anesthetics

        10.6.4. NSAIDS

        10.6.5. Opioids

            10.6.5.1. Oxycodones

            10.6.5.2. Hydrocodones

            10.6.5.3. Tramadol

            10.6.5.4. Others

        10.6.6. Antimigraine Agents

        10.6.7. Other Non-narcotic Analgesic

    10.7. North America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication

    10.8. North America Pain Management Therapeutics Market Forecast, by Indication

        10.8.1. Neuropathic Pain 

        10.8.2. Fibromyalgia 

        10.8.3. Arthritic Pain 

        10.8.4. Chronic Back Pain 

        10.8.5. Migraine 

        10.8.6. Post-Operative Pain 

        10.8.7. Cancer Pain

11. Europe Pain Management Therapeutics Market Analysis

    11.1. Key Findings

    11.2. Europe Pain Management Therapeutics Market Overview

    11.3. Europe Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    11.4. Europe Pain Management Therapeutics Market Forecast, by Country/Sub-region

        11.4.1. Germany

        11.4.2. U.K.

        11.4.3. France

        11.4.4. Italy

        11.4.5. Spain

        11.4.6. Rest of Europe

    11.5. Europe Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics

    11.6. Europe Pain Management Therapeutics Market Forecast, by Therapeutics

        11.6.1. Anticonvulsants

        11.6.2. Antidepressants

        11.6.3. Anesthetics

        11.6.4. NSAIDS

        11.6.5. Opioids

            11.6.5.1. Oxycodones

            11.6.5.2. Hydrocodones

            11.6.5.3. Tramadol

            11.6.5.4. Others

        11.6.6. Antimigraine Agents

        11.6.7. Other Non-narcotic Analgesic

    11.7. Europe Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication

    11.8. Europe Pain Management Therapeutics Market Forecast, by Indication

        11.8.1. Neuropathic Pain 

        11.8.2. Fibromyalgia 

        11.8.3. Arthritic Pain 

        11.8.4. Chronic Back Pain 

        11.8.5. Migraine 

        11.8.6. Post-Operative Pain 

        11.8.7. Cancer Pain 

12. Asia Pacific Pain Management Therapeutics Market Analysis

    12.1. Key Findings

    12.2. Asia Pacific Pain Management Therapeutics Market Overview

    12.3. Asia Pacific Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    12.4. Asia Pacific Pain Management Therapeutics Market Forecast, by Country/Sub-region

        12.4.1. China

        12.4.2. Japan

        12.4.3. India

        12.4.4. Australia & New Zealand

        12.4.5. Rest of Asia Pacific

    12.5. Asia Pacific Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics

    12.6. Asia Pacific Pain Management Therapeutics Market Forecast, by Therapeutics

        12.6.1. Anticonvulsants

        12.6.2. Antidepressants

        12.6.3. Anesthetics

        12.6.4. NSAIDS

        12.6.5. Opioids

            12.6.5.1. Oxycodones

            12.6.5.2. Hydrocodones

            12.6.5.3. Tramadol

            12.6.5.4. Others

        12.6.6. Antimigraine Agents

        12.6.7. Other Non-narcotic Analgesic

    12.7. Asia Pacific Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication

    12.8. Asia Pacific Pain Management Therapeutics Market Forecast, by Indication

        12.8.1. Neuropathic Pain 

        12.8.2. Fibromyalgia 

        12.8.3. Arthritic Pain 

        12.8.4. Chronic Back Pain 

        12.8.5. Migraine 

        12.8.6. Post-Operative Pain 

        12.8.7. Cancer Pain

13. Latin America Pain Management Therapeutics Market Analysis

    13.1. Key Findings

    13.2. Latin America Pain Management Therapeutics Market Overview

    13.3. Latin America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    13.4. Latin America Pain Management Therapeutics Market Forecast, by Country/Sub-region

        13.4.1. Brazil

        13.4.2. Mexico

        13.4.3. Rest of Latin America

    13.5. Latin America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics

    13.6. Latin America Pain Management Therapeutics Market Forecast, by Therapeutics

        13.6.1. Anticonvulsants

        13.6.2. Antidepressants

        13.6.3. Anesthetics

        13.6.4. NSAIDS

        13.6.5. Opioids

            13.6.5.1. Oxycodones

            13.6.5.2. Hydrocodones

            13.6.5.3. Tramadol

            13.6.5.4. Others

        13.6.6. Antimigraine Agents

        13.6.7. Other Non-narcotic Analgesic

    13.7. Latin America Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication

    13.8. Latin America Pain Management Therapeutics Market Forecast, by Indication

        13.8.1. Neuropathic Pain 

        13.8.2. Fibromyalgia 

        13.8.3. Arthritic Pain 

        13.8.4. Chronic Back Pain 

        13.8.5. Migraine 

        13.8.6. Post-Operative Pain 

        13.8.7. Cancer Pain

14. Middle East & Africa Pain Management Therapeutics Market Analysis

    14.1. Key Findings

    14.2. Middle East & Africa Pain Management Therapeutics Market Overview

    14.3. Middle East & Africa Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Country/Sub-region

    14.4. Middle East & Africa Pain Management Therapeutics Market Forecast, by Country/Sub-region

        14.4.1. GCC Countries

        14.4.2. South Africa

        14.4.3. Rest of Middle East & Africa

    14.5. Middle East & Africa Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Therapeutics

    14.6. Middle East & Africa Pain Management Therapeutics Market Forecast, by Therapeutics

        14.6.1. Anticonvulsants

        14.6.2. Antidepressants

        14.6.3. Anesthetics

        14.6.4. NSAIDS

        14.6.5. Opioids

            14.6.5.1. Oxycodones

            14.6.5.2. Hydrocodones

            14.6.5.3. Tramadol

            14.6.5.4. Others

        14.6.6. Antimigraine Agents

        14.6.7. Other Non-narcotic Analgesic

    14.7. Middle East & Africa Pain Management Therapeutics Market Value Share and Attractiveness Analysis, by Indication

    14.8. Middle East & Africa Pain Management Therapeutics Market Forecast, by Indication

        14.8.1. Neuropathic Pain 

        14.8.2. Fibromyalgia 

        14.8.3. Arthritic Pain 

        14.8.4. Chronic Back Pain 

        14.8.5. Migraine 

        14.8.6. Post-Operative Pain 

        14.8.7. Cancer Pain

15. Competition Landscape

    15.1. Market Player - Competition Matrix (by Tier and Size of companies)

    15.2. Market Share / Position Analysis, by Company, 2018

    15.3. Company Profiles

        15.3.1. Pfizer Inc

            15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.1.2. Growth Strategies

            15.3.1.3. SWOT Analysis

        15.3.2. Depomed, Inc. 

            15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.2.2. Growth Strategies

            15.3.2.3. SWOT Analysis

        15.3.3. Endo International plc. 

            15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.3.2. Growth Strategies

            15.3.3.3. SWOT Analysis

        15.3.4. Mankind Pharma Ltd. 

            15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.4.2. Growth Strategies

            15.3.4.3. SWOT Analysis

        15.3.5. Merck & Co, Inc.

            15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.5.2. Growth Strategies

            15.3.5.3. SWOT Analysis

        15.3.6. Pfizer, Inc. 

            15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.6.2. Growth Strategies

            15.3.6.3. SWOT Analysis 

        15.3.7. Teva Pharmaceutical Industries Ltd. 

            15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.7.2. Growth Strategies

            15.3.7.3. SWOT Analysis

        15.3.8. Lupin Limited 

            15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.8.2. Growth Strategies

            15.3.8.3. SWOT Analysis

        15.3.9. Piramal Enterprises

            15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.9.2. Growth Strategies

            15.3.9.3. SWOT Analysis

        15.3.10. Syzygy Healthcare LLC 

            15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            15.3.10.2. Growth Strategies

            15.3.10.3. SWOT Analysis

List of Table

Table 1 Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027

Table 2 Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027

Table 3 Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 4 Global Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 5 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 6 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027

Table 7 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027

Table 8 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 9 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027

Table 11 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027

Table 12 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 13 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 14 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027

Table 15 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027

Table 16 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 17 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027

Table 19 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027

Table 20 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 21 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2017–2027

Table 23 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Opioids, 2017–2027

Table 24 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast, by Indication, 2017–2027

List of Figure

Figure 1 Global Pain Management Therapeutics Market Value (US$ Mn) and Distribution (%), by Region, 2018 and 2027

Figure 2 Global Pain Management Therapeutics Market Value (US$ Mn) and Forecast, 2019–2027

Figure 3 Global Pain Management Therapeutics Market Value Share (%), by Therapeutics, 2018

Figure 4 Global Pain Management Therapeutics Market Value Share (%), by Indication, 2018

Figure 5 Global Pain Management Therapeutics Market Value Share (%), by Region, 2018

Figure 6 Global Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027

Figure 7 Global Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027

Figure 8 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anticonvulsants, 2017–2027

Figure 9 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antidepressants, 2017–2027

Figure 10 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Anesthetics, 2017–2027

Figure 11 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by NSAIDS, 2017–2027

Figure 12 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Opioids, 2017–2027

Figure 13 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Antimigraine Agents, 2017–2027

Figure 14 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Other Non-narcotic Analgesic, 2017–2027

Figure 15 Global Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027

Figure 16 Global Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027

Figure 17 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Neuropathic Pain, 2017–2027

Figure 18 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Fibromyalgia, 2017–2027

Figure 19 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Arthritic Pain, 2017–2027

Figure 20 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chronic Back Pain, 2017–2027

Figure 21 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Migraine, 2017–2027

Figure 22 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Post-Operative Pain, 2017–2027

Figure 23 Global Pain Management Therapeutics Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Pain, 2017–2027

Figure 24 Global Pain Management Therapeutics Market Value Share, by Region, 2018 and 2027 

Figure 25 Global Pain Management Therapeutics Market Attractiveness, by Region, 2019–2027

Figure 26 North America Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 27 North America Pain Management Therapeutics Market Value Share Analysis, by Country, 2018 and 2027

Figure 28 North America Pain Management Therapeutics Market Attractiveness, by Country, 2019–2027

Figure 29 North America Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027

Figure 30 North America Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027

Figure 31 North America Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027

Figure 32 North America Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027

Figure 33 Europe Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 34 Europe Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 35 Europe Pain Management Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 36 Europe Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027

Figure 37 Europe Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027

Figure 38 Europe Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027

Figure 39 Europe Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027

Figure 40 Asia Pacific Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 41 Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 42 Asia Pacific Pain Management Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 43 Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027

Figure 44 Asia Pacific Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027

Figure 45 Asia Pacific Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027

Figure 46 Asia Pacific Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027

Figure 47 Latin America Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 48 Latin America Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 49 Latin America Pain Management Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 50 Latin America Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027

Figure 51 Latin America Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027

Figure 52 Latin America Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027

Figure 53 Latin America Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027

Figure 54 Middle East & Africa Pain Management Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 55 Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 56 Middle East & Africa Pain Management Therapeutics Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 57 Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, by Therapeutics, 2018 and 2027

Figure 58 Middle East & Africa Pain Management Therapeutics Market Attractiveness, by Therapeutics, 2019–2027

Figure 59 Middle East & Africa Pain Management Therapeutics Market Value Share Analysis, by Indication, 2018 and 2027

Figure 60 Middle East & Africa Pain Management Therapeutics Market Attractiveness, by Indication, 2019–2027

Figure 61 Global Pain Management Therapeutics Market Share Analysis, by Company, 2018

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Pain Management Therapeutics Market